News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Aging | Body Weight Influences Musculoskeletal Adaptation to Running in Aging Mice

Aging

February 8, 2023
PRESS RELEASE: A new research paper was published in Aging's Volume 15, Issue 2, entitled, “Body weight influences musculoskeletal adaptation to long-term voluntary wheel running during aging in female mice.” continue reading »

Oncotarget | The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

News

February 7, 2023
PRESS RELEASE: On February 4, 2023, Oncotarget published a new research perspective, entitled, “The immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy.” continue reading »

Genes & Cancer | Leveraging Allogeneic Dendritic Cells for Neoantigen Cancer Vaccines

News

February 3, 2023
PRESS RELEASE: On January 30, 2023, a new research perspective was published in Genes & Cancer, entitled, “Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.” continue reading »

Aging | Are menopause, aging and prostate cancer diseases?

Aging

February 2, 2023
PRESS RELEASE: Dr. Blagosklonny published a new research perspective in Aging's Volume 15, Issue 2, entitled, “Are menopause, aging and prostate cancer diseases?” continue reading »

Oncotarget | Mivavotinib for Relapsed/Refractory B-cell Lymphoma (Updated)

News

February 1, 2023
PRESS RELEASE: On January 26, 2023, a new research paper was published in Oncotarget, entitled, “Spleen tyrosine kinase/FMS-like tyrosine kinase-3 inhibition in relapsed/refractory B-cell lymphoma, including diffuse large B-cell lymphoma: updated data with mivavotinib (TAK-659/CB-659).” continue reading »